{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/54.1-3307.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/54.1-3307.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/54.1-3307.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/54.1-3307.html"}],"law_id":56891,"edition_id":1,"section_id":56891,"structure_id":14478,"section_number":"54.1-3307","catch_line":"Specific powers and duties of Board","history":"Code 1950, \u00a7\u00a7 54-415, 54-416.1; 1954, c. 396; 1958, c. 551, \u00a7 54-524.16; 1970, c. 650, \u00a7 54-524.18; 1972, c. 798; 1980, c. 288; 1988, c. 765; 1995, c. 529; 1996, cc. 37, 407; 2005, c. 777; 2006, c. 632; 2016, c. 221; 2020, c. 1166; 2021, Sp. Sess. I, cc. 344, 345.","full_text":"A\n\nThe Board shall regulate the practice of pharmacy and the manufacturing, dispensing, selling, distributing, processing, compounding, or disposal of drugs and devices. The Board shall also control the character and standard of all drugs, cosmetics, and devices within the Commonwealth, investigate all complaints as to the quality and strength of all drugs, cosmetics, and devices, and take such action as may be necessary to prevent the manufacturing, dispensing, selling, distributing, processing, compounding, and disposal of such drugs, cosmetics, and devices that do not conform to the requirements of law.\n\t\t\tThe Board’s regulations shall include criteria for:1\n\nMaintenance of the quality, quantity, integrity, safety, and efficacy of drugs or devices distributed, dispensed, or administered.2\n\nCompliance with the prescriber’s instructions regarding the drug and its quantity, quality, and directions for use.3\n\nControls and safeguards against diversion of drugs or devices.4\n\nMaintenance of the integrity of, and public confidence in, the profession and improving the delivery of quality pharmaceutical services to the citizens of Virginia.5\n\nMaintenance of complete records of the nature, quantity, or quality of drugs or substances distributed or dispensed and of all transactions involving controlled substances or drugs or devices so as to provide adequate information to the patient, the practitioner, or the Board.6\n\nControl of factors contributing to abuse of legitimately obtained drugs, devices, or controlled substances.7\n\nPromotion of scientific or technical advances in the practice of pharmacy and the manufacture and distribution of controlled drugs, devices, or substances.8\n\nImpact on costs to the public and within the health care industry through the modification of mandatory practices and procedures not essential to meeting the criteria set out in subdivisions 1 through 7.9\n\nSuch other factors as may be relevant to, and consistent with, the public health and safety and the cost of rendering pharmacy services.B\n\nThe Board may collect and examine specimens of drugs, devices, and cosmetics that are manufactured, distributed, stored, or dispensed in the Commonwealth.","order_by":null,"text":{"0":{"id":208382,"text":"The Board shall regulate the practice of pharmacy and the manufacturing, dispensing, selling, distributing, processing, compounding, or disposal of drugs and devices. The Board shall also control the character and standard of all drugs, cosmetics, and devices within the Commonwealth, investigate all complaints as to the quality and strength of all drugs, cosmetics, and devices, and take such action as may be necessary to prevent the manufacturing, dispensing, selling, distributing, processing, compounding, and disposal of such drugs, cosmetics, and devices that do not conform to the requirements of law.\n\t\t\tThe Board’s regulations shall include criteria for:","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"A1"},"1":{"id":208383,"text":"Maintenance of the quality, quantity, integrity, safety, and efficacy of drugs or devices distributed, dispensed, or administered.","type":"section","prefixes":["A","1"],"prefix":"1","entire_prefix":"A1","prefix_anchor":"A1","level":2,"prior_prefix":"A","next_prefix":"A2"},"2":{"id":208384,"text":"Compliance with the prescriber’s instructions regarding the drug and its quantity, quality, and directions for use.","type":"section","prefixes":["A","2"],"prefix":"2","entire_prefix":"A2","prefix_anchor":"A2","level":2,"prior_prefix":"A1","next_prefix":"A3"},"3":{"id":208385,"text":"Controls and safeguards against diversion of drugs or devices.","type":"section","prefixes":["A","3"],"prefix":"3","entire_prefix":"A3","prefix_anchor":"A3","level":2,"prior_prefix":"A2","next_prefix":"A4"},"4":{"id":208386,"text":"Maintenance of the integrity of, and public confidence in, the profession and improving the delivery of quality pharmaceutical services to the citizens of Virginia.","type":"section","prefixes":["A","4"],"prefix":"4","entire_prefix":"A4","prefix_anchor":"A4","level":2,"prior_prefix":"A3","next_prefix":"A5"},"5":{"id":208387,"text":"Maintenance of complete records of the nature, quantity, or quality of drugs or substances distributed or dispensed and of all transactions involving controlled substances or drugs or devices so as to provide adequate information to the patient, the practitioner, or the Board.","type":"section","prefixes":["A","5"],"prefix":"5","entire_prefix":"A5","prefix_anchor":"A5","level":2,"prior_prefix":"A4","next_prefix":"A6"},"6":{"id":208388,"text":"Control of factors contributing to abuse of legitimately obtained drugs, devices, or controlled substances.","type":"section","prefixes":["A","6"],"prefix":"6","entire_prefix":"A6","prefix_anchor":"A6","level":2,"prior_prefix":"A5","next_prefix":"A7"},"7":{"id":208389,"text":"Promotion of scientific or technical advances in the practice of pharmacy and the manufacture and distribution of controlled drugs, devices, or substances.","type":"section","prefixes":["A","7"],"prefix":"7","entire_prefix":"A7","prefix_anchor":"A7","level":2,"prior_prefix":"A6","next_prefix":"A8"},"8":{"id":208390,"text":"Impact on costs to the public and within the health care industry through the modification of mandatory practices and procedures not essential to meeting the criteria set out in subdivisions 1 through 7.","type":"section","prefixes":["A","8"],"prefix":"8","entire_prefix":"A8","prefix_anchor":"A8","level":2,"prior_prefix":"A7","next_prefix":"A9"},"9":{"id":208391,"text":"Such other factors as may be relevant to, and consistent with, the public health and safety and the cost of rendering pharmacy services.","type":"section","prefixes":["A","9"],"prefix":"9","entire_prefix":"A9","prefix_anchor":"A9","level":2,"prior_prefix":"A8","next_prefix":"B"},"10":{"id":208392,"text":"The Board may collect and examine specimens of drugs, devices, and cosmetics that are manufactured, distributed, stored, or dispensed in the Commonwealth.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A9"}},"ancestry":[{"id":14478,"edition_id":1,"name":"Board of Pharmacy","identifier":"2","label":"article","depth":4,"order_by":1,"parent_id":13496,"metadata":{},"date_created":"2026-06-26 03:48:16","date_modified":"2026-06-26 03:48:16","permalink":{"id":243129,"object_type":"structure","relational_id":14478,"identifier":"2","token":"54.1\/III\/33\/2","url":"\/54.1\/III\/33\/2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13496,"edition_id":1,"name":"Pharmacy","identifier":"33","label":"chapter","depth":3,"order_by":1,"parent_id":12758,"metadata":{},"date_created":"2026-06-26 03:45:04","date_modified":"2026-06-26 03:45:04","permalink":{"id":243093,"object_type":"structure","relational_id":13496,"identifier":"33","token":"54.1\/III\/33","url":"\/54.1\/III\/33\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12758,"edition_id":1,"name":"Professions and Occupations Regulated by Boards Within the Department of Health Professions","identifier":"III","label":"subtitle","depth":2,"order_by":1,"parent_id":12754,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":241105,"object_type":"structure","relational_id":12758,"identifier":"III","token":"54.1\/III","url":"\/54.1\/III\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12754,"edition_id":1,"name":"Professions and Occupations","identifier":"54.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":239313,"object_type":"structure","relational_id":12754,"identifier":"54.1","token":"54.1","url":"\/54.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":74398,"structure_id":14478,"section_number":"54.1-3305","catch_line":"Board; membership; terms; meetings; quorum; officers","url":"\/54.1-3305\/","token":"54.1\/III\/33\/2\/54.1-3305","metadata":false},{"id":64309,"structure_id":14478,"section_number":"54.1-3306","catch_line":"Nominations","url":"\/54.1-3306\/","token":"54.1\/III\/33\/2\/54.1-3306","metadata":false},{"id":56891,"structure_id":14478,"section_number":"54.1-3307","catch_line":"Specific powers and duties of Board","url":"\/54.1-3307\/","token":"54.1\/III\/33\/2\/54.1-3307","metadata":false},{"id":55865,"structure_id":14478,"section_number":"54.1-3307.1","catch_line":"Repealed","url":"\/54.1-3307.1\/","token":"54.1\/III\/33\/2\/54.1-3307.1","metadata":false},{"id":70469,"structure_id":14478,"section_number":"54.1-3307.2","catch_line":"Approval of innovative programs","url":"\/54.1-3307.2\/","token":"54.1\/III\/33\/2\/54.1-3307.2","metadata":false},{"id":57744,"structure_id":14478,"section_number":"54.1-3307.3","catch_line":"Waiver of requirements; declared disaster or state of emergency","url":"\/54.1-3307.3\/","token":"54.1\/III\/33\/2\/54.1-3307.3","metadata":false},{"id":57403,"structure_id":14478,"section_number":"54.1-3308","catch_line":"Power of inspection","url":"\/54.1-3308\/","token":"54.1\/III\/33\/2\/54.1-3308","metadata":false},{"id":82048,"structure_id":14478,"section_number":"54.1-3309","catch_line":"Enforcement","url":"\/54.1-3309\/","token":"54.1\/III\/33\/2\/54.1-3309","metadata":false}],"previous_section":{"id":64309,"structure_id":14478,"section_number":"54.1-3306","catch_line":"Nominations","url":"\/54.1-3306\/","token":"54.1\/III\/33\/2\/54.1-3306","metadata":false},"next_section":{"id":55865,"structure_id":14478,"section_number":"54.1-3307.1","catch_line":"Repealed","url":"\/54.1-3307.1\/","token":"54.1\/III\/33\/2\/54.1-3307.1","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/54.1-3307\/","history_text":"

The record of this law\u2019s original creation isn\u2019t available online. It has been modified 12 times. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. Those modifications are as follows: in 1954, chapter 396; in 1958, chapter 551; in 1970, chapter 650; in 1972, chapter 798; in 1980, chapter 288; in 1988, chapter 765; in 1995, chapter 529<\/a>; in 1996, chapters 37<\/a> and 407<\/a>; in 2005, chapter 777<\/a>; in 2006, chapter 632<\/a>; in 2016, chapter 221<\/a>; in 2020, chapter 1166<\/a>.<\/p>","references":false,"refers_to":false,"permalink":{"id":243139,"object_type":"law","relational_id":56891,"identifier":"54.1-3307","token":"54.1\/III\/33\/2\/54.1-3307","url":"\/54.1-3307\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/54.1-3307\/","token":"54.1\/III\/33\/2\/54.1-3307","dublin_core":{"Title":"Specific powers and duties of Board","Type":"Text","Format":"text\/html","Identifier":"\u00a7 54.1-3307","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> The Board<\/span> shall regulate the practice of pharmacy<\/span> and the manufacturing, dispensing, selling, distributing, processing, compounding, or disposal of drugs and devices. The Board<\/span> shall also control the character and standard of all drugs, cosmetics, and devices within the Commonwealth, investigate all complaints as to the quality and strength of all drugs, cosmetics, and devices, and take such action as may be necessary to prevent the manufacturing, dispensing, selling, distributing, processing, compounding, and disposal of such drugs, cosmetics, and devices that do not conform to the requirements of law<\/span>.\n\t\t\tThe Board<\/span>’s regulations shall include criteria for: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> Maintenance of the quality, quantity, integrity, safety, and efficacy of drugs or devices distributed, dispensed, or administered. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> Compliance with the prescriber’s instructions regarding the drug and its quantity, quality, and directions for use. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

3.<\/span> Controls and safeguards against diversion<\/span> of drugs or devices. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

4.<\/span> Maintenance of the integrity of, and public confidence in, the profession and improving the delivery of quality pharmaceutical services to the citizens of Virginia. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

5.<\/span> Maintenance of complete records of the nature, quantity, or quality of drugs or substances distributed or dispensed and of all transactions involving controlled substances or drugs or devices so as to provide adequate information to the patient, the practitioner, or the Board<\/span>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

6.<\/span> Control of factors contributing to abuse of legitimately obtained drugs, devices, or controlled substances. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

7.<\/span> Promotion of scientific or technical advances in the practice of pharmacy<\/span> and the manufacture and distribution of controlled drugs, devices, or substances. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

8.<\/span> Impact on costs to the public and within the health care industry through the modification of mandatory practices and procedures not essential to meeting the criteria set out in subdivisions 1 through 7. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

9.<\/span> Such other factors as may be relevant to, and consistent with, the public health and safety and the cost of rendering pharmacy services. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> The Board<\/span> may collect and examine specimens of drugs, devices, and cosmetics that are manufactured, distributed, stored, or dispensed in the Commonwealth. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nSPECIFIC POWERS AND DUTIES OF BOARD (\u00a7 54.1-3307)\n\nA. The Board shall regulate the practice of pharmacy and the manufacturing,\ndispensing, selling, distributing, processing, compounding, or disposal of drugs\nand devices. The Board shall also control the character and standard of all\ndrugs, cosmetics, and devices within the Commonwealth, investigate all\ncomplaints as to the quality and strength of all drugs, cosmetics, and devices,\nand take such action as may be necessary to prevent the manufacturing,\ndispensing, selling, distributing, processing, compounding, and disposal of such\ndrugs, cosmetics, and devices that do not conform to the requirements of law.\n\t\t\tThe Board’s regulations shall include criteria for:\n\n 1. Maintenance of the quality, quantity, integrity, safety, and efficacy of\n drugs or devices distributed, dispensed, or administered.\n\n 2. Compliance with the prescriber’s instructions regarding the drug and\n its quantity, quality, and directions for use.\n\n 3. Controls and safeguards against diversion of drugs or devices.\n\n 4. Maintenance of the integrity of, and public confidence in, the profession\n and improving the delivery of quality pharmaceutical services to the citizens\n of Virginia.\n\n 5. Maintenance of complete records of the nature, quantity, or quality of\n drugs or substances distributed or dispensed and of all transactions involving\n controlled substances or drugs or devices so as to provide adequate\n information to the patient, the practitioner, or the Board.\n\n 6. Control of factors contributing to abuse of legitimately obtained drugs,\n devices, or controlled substances.\n\n 7. Promotion of scientific or technical advances in the practice of pharmacy\n and the manufacture and distribution of controlled drugs, devices, or\n substances.\n\n 8. Impact on costs to the public and within the health care industry through\n the modification of mandatory practices and procedures not essential to\n meeting the criteria set out in subdivisions 1 through 7.\n\n 9. Such other factors as may be relevant to, and consistent with, the public\n health and safety and the cost of rendering pharmacy services.\n\nB. The Board may collect and examine specimens of drugs, devices, and cosmetics\nthat are manufactured, distributed, stored, or dispensed in the Commonwealth.\n\nHISTORY: Code 1950, \u00a7\u00a7 54-415, 54-416.1; 1954, c. 396; 1958, c. 551, \u00a7\n54-524.16; 1970, c. 650, \u00a7 54-524.18; 1972, c. 798; 1980, c. 288; 1988, c. 765;\n1995, c. 529; 1996, cc. 37, 407; 2005, c. 777; 2006, c. 632; 2016, c. 221; 2020,\nc. 1166; 2021, Sp. Sess. I, cc. 344, 345.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}